Melt extrusion: process to product

Authors: Repka, Michael A1; Shah, Sejal2; Lu, Jiannan2; Maddineni, Sindhuri2; Morott, Joe2; Patwardhan, Ketaki2; Mohammed, Noorullah Naqvi2

Source: Expert Opinion on Drug Delivery, Volume 9, Number 1, January 2012 , pp. 105-125(21)

Publisher: Informa Healthcare

Buy & download fulltext article:


Price: $99.00 plus tax (Refund Policy)


Introduction: Niche applicability and industrial adaptability have led hot melt extrusion (HME) techniques to gain wide acceptance and have, therefore, solidified their place in the array of pharmaceutical research and manufacturing operations. Melt extrusion's momentum has resulted in extensive research publications, reviews and patents on the subject for over a decade. Currently, > 50% of the new drug candidates are speculated to be highly lipophilic and thus poorly bioavailable. HME is a key technology for these and other formulation and processing issues.

Areas covered: Various approaches have been addressed using HME in developing solid molecular dispersions and have demonstrated viability to provide sustained, modified and targeted drug delivery resulting in improved bioavailability. This review provides a holistic perspective on HME from equipment, processing and materials to its varied applications in oral delivery (immediate release, sustained release, taste masking, enteric and targeted release, as well as trans-drug delivery), oral mucosal, dermal, ungual and intravaginal systems.

Expert opinion: Interest in HME as a pharmaceutical process continues to grow and the potential of automation and reduction of capital investment and labor costs has earned this technique a necessary consideration as a drug delivery solution.

Keywords: bioadhesion; bioavailability; controlled release; drug delivery systems; hot melt extrusion; melt extruded films; melt extruded tablets; solid dispersion; sustained release

Document Type: Research Article


Affiliations: 1: 1 The University of Mississippi, School of Pharmacy, Department of Pharmaceutics, University, MS 38677, USA ++662 915 1155; ++662 915 1177;, Email: 2: 2 The University of Mississippi, Research Institute of Pharmaceutical Sciences, University, MS 38677, USA

Publication date: January 1, 2012

More about this publication?
Related content


Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page